logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > AZD-4635 CAS 1321514-06-0

AZD-4635 CAS 1321514-06-0

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1321514-06-0

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
1321514-06-0
Appearance::
Solid Or Powder
Molecular Formula::
C15H11ClFN5
Molecular Weight::
315.73300
EINECS NO::
NA
MDL NO::
NA
CAS NO::
1321514-06-0
Appearance::
Solid Or Powder
Molecular Formula::
C15H11ClFN5
Molecular Weight::
315.73300
EINECS NO::
NA
MDL NO::
NA
AZD-4635 CAS 1321514-06-0

Product Description:

Product Name: AZD-4635 CAS NO: 1321514-06-0

 

 

Synonyms:

HTL-1071;

1,2,4-Triazin-3-amine, 6-(2-chloro-6-methyl-4-pyridinyl)-5-(4-fluorophenyl)-;

6-(2-chloro-6-methylpyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine;

 

 

Chemical & Physical Properties:

Appearance: Solid or powder

Assay :≥99.0%

Boiling Point: 491.5±55.0℃(Predicted)

Density: 1.387±0.06 g/cm3 (Predicted)

PKa: 1.75±0.63 (Predicted)

 

 

Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that can bind to human A2AR with a Ki value of 1.7 nM, which is more than 30 times more selective for A2AR than other adenosine receptors. In CHO cells stably expressing human A2AR, AZD4625 inhibited cAMP production with IC50 values of 0.79, 10.0 and 142.9 nM in the presence of 0.1, 1 and 10 μmadenosine, respectively. Inhibition of A2AR by AZD4625 can reduce tumor load and enhance anti-tumor immunity.

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.